Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management – 2024-03-05 17:31:22

Manchester, England (ots/PRNewswire) – Phagenesis, a pioneering UK company which has developed a revolutionary neurostimulation system to treat swallowing dysfunction, has closed a M Series D financing all equity investment…
The post Phagenesis, a medical device company specializing in the treatment
of swallowing disorders, successfully closes a M Series D
financing round led by EQT Life Sciences and Sectoral Asset
Management
– 2024-03-05 17:31:22 appeared first on Worldys News.